Why AML Is Sensitive to Mitochondrial Drugs
2026-08-31
Panina and colleagues show that acute myeloid leukemia (AML) is unusually sensitive to mitochondrial-targeting drugs because of distinct defects in mitochondrial metabolism and respiratory coupling. Their combination of NCI-60 computational analysis, mitochondrial phenotyping, leukemia models, and primary AML samples also identifies strong synergy between the mitochondrial uncoupler CCCP and glycolytic inhibitor 2-deoxyglucose, while suggesting a therapeutic window over normal blood cells.
Doxorubicin Hydrochloride: Mechanism & Research Use
2026-08-30
Doxorubicin hydrochloride, also called Adriamycin HCl, is an anthracycline DNA topoisomerase II inhibitor used in cancer chemotherapy research. Its value in cell and animal studies depends on separating reproducible cytotoxicity measurements from exposure-dependent cardiotoxicity and formulation effects.
Cationic Lipid-Enriched LNPs for mRNA Vaccines
2026-08-29
This 2025 study evaluates whether adding the cationic lipid DOTAP to ALC-0315-based lipid nanoparticles can shift intramuscular mRNA expression toward the injection site while limiting hepatic expression. The results show that modest DOTAP incorporation improved local reporter expression and produced a transient prime-dose antibody advantage, but did not deliver a sustained immunogenicity benefit after boosting.
Syringin Enhances Sunitinib in Renal Cell Carcinoma
2026-08-29
A 2024 Journal of Functional Foods study identifies Syringin as a potential adjunct to Sunitinib in renal cell carcinoma (RCC). By combining network pharmacology, molecular docking, bioinformatics, and cell-based validation, the authors link Syringin activity to EGFR/PI3K/Akt signaling, reduced RCC aggressiveness, and greater Sunitinib sensitivity.
CCC, Ferroptosis, and TM3 Leydig Cell Growth
2026-08-28
Wang and colleagues identified ferroptosis-initiated inflammation as a major contributor to chlormequat chloride-induced growth inhibition in TM3 Leydig cells. Their pharmacological rescue and ferritin light-chain experiments connect lipid peroxidation, inflammatory signaling, and impaired cell viability, while also showing why viability measurements should be interpreted with orthogonal mechanistic assays.
AP20187: A Decision Framework for Conditional Signaling
2026-08-28
AP20187 is a chemical inducer of dimerization that converts engineered protein interactions into controllable cellular signals. This guide presents an assay-centered framework linking conditional signaling to microenvironment-aware studies of senescent cancer-associated fibroblasts and NK-cell function.
Bradford Protein Assay Kit: Practical Workflow
2026-08-27
The Bradford Protein Assay Kit (K4103) provides a fast colorimetric method for protein concentration measurement from small sample volumes. It is suited to routine protein quantification in compatible buffers, but samples containing substantial detergent or unusual buffer components require validation before use.
ER Stress, GRP78/ATF6/CHOP, and Intestinal Stem Cells
2026-08-27
This version 1 study links tunicamycin-induced endoplasmic reticulum stress with intestinal stem-cell depletion, impaired epithelial differentiation, reduced crypt proliferation, and increased apoptosis in mice. Its main contribution is a connected model in which GRP78/ATF6/CHOP activation and p44/42 MAPK inhibition accompany damage to the small-intestinal stem-cell niche and barrier.
ER-Fusogenic Liposomes Strengthen Antitumor Vaccines
2026-08-26
The reference study introduces phosphatidylinositol-based immunomodulatory nanoliposomes that combine intrinsic adjuvant activity with endoplasmic-reticulum membrane fusion. In murine models, OVA-loaded PI-INLs enhanced CD8 T-cell responses and tumor protection relative to MF59-adjuvanted OVA, supporting a self-adjuvanting strategy for cellular cancer vaccines.
Cy5.5 NHS ester for Nanoplatform Imaging
2026-08-26
Cy5.5 NHS ester (non-sulfonated) turns amine-bearing proteins, peptides, oligonucleotides, and nanocarriers into trackable near-infrared probes. This workflow shows how to use it to map ultrasound-responsive piezoelectric platforms while preserving a clear distinction between biodistribution data and evidence of neuromodulation.
Dronedarone (Multaq) in AF Research Workflows
2026-08-25
Translate Dronedarone pharmacology into reproducible ion-channel, exposure, and atrial arrhythmia assays. This workflow emphasizes solvent control, therapeutic-range benchmarking, and the KCa2 channel findings that distinguish direct evidence from testable research hypotheses.
Prion-Based Mutagenesis and Rapid Adaptation
2026-08-25
The Cell study shows that prion-like self-assembly of DNA repair and recombination proteins can reversibly and heritably tune mutagenesis, helping fungal populations adapt under strong selection. Its cross-species evidence links prion maintenance to drug resistance and provides a framework for studying how epigenetic memory reshapes genome stability.
Sulforaphane Attenuates PM2.5-Driven COPD
2026-08-24
The reference study integrates rat and cell models with network pharmacology, molecular docking, and pathway perturbation to show that sulforaphane mitigates PM2.5-associated COPD features through Nrf2 activation and suppression of EGFR/PI3K/AKT signaling. Its design provides a useful framework for connecting redox measurements with inflammation, mucus production, tissue injury, and pathway-level validation.
Antipyrine in BBB Permeability Workflows
2026-08-23
Antipyrine combines high aqueous solubility with research-grade purity, making it a practical comparator for transport, recovery, and exposure workflows. This guide shows how to integrate it into LLC-PK1-MOCK/MDR1 assays while avoiding false permeability signals caused by barrier failure, precipitation, or intracellular trapping.
Deferiprone B1723: Reliable Iron Chelation
2026-08-22
Learn how Deferiprone (SKU B1723) can improve the design and interpretation of iron-dependent viability, proliferation, and cytotoxicity assays. This scenario-based guide connects formulation, exposure planning, metabolic readouts, and vendor selection with current enterocyte and cancer biology evidence.
508 records 10/34 page Previous Next First page 上5页 678910 下5页 Last page